Response to peginterferon-alpha 2b and ribavirin in Japanese patients with chronic hepatitis C genotype 1

被引:0
|
作者
Tomoo Miyauchi
Tatsuo Kanda
Fumio Imazeki
Rintaro Mikata
Akinobu Tawada
Makoto Arai
Keiichi Fujiwara
Shingo Nakamoto
Shuang Wu
Takeshi Tanaka
Tatsuo Miyamura
Michio Kimura
Yasuo Hirai
Motohide Takashi
Shigeru Mikami
Nobuyuki Sugiura
Yutaka Natsuki
Ryosaku Azemoto
Noriaki Suzuki
Osamu Yokosuka
机构
[1] Chiba University,Department of Medicine and Clinical Oncology, Graduate School of Medicine
[2] Social Insurance Funabashi Chuo Hospital,undefined
[3] Matsudo City Hospital,undefined
[4] Saiseikai Narashino Hospital,undefined
[5] Kikkoman Hospital,undefined
[6] National Hospital Organization Chiba Medical Center,undefined
[7] Sannou Hospital Medical Center,undefined
[8] Kimitsu Chuo Hospital,undefined
来源
关键词
Age; Gender; Genotype 1; HCV; Ribavirin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:144 / 152
页数:8
相关论文
共 50 条
  • [1] Response to peginterferon-alpha 2b and ribavirin in Japanese patients with chronic hepatitis C genotype 1
    Miyauchi, Tomoo
    Kanda, Tatsuo
    Imazeki, Fumio
    Mikata, Rintaro
    Tawada, Akinobu
    Arai, Makoto
    Fujiwara, Keiichi
    Nakamoto, Shingo
    Wu, Shuang
    Tanaka, Takeshi
    Miyamura, Tatsuo
    Kimura, Michio
    Hirai, Yasuo
    Takashi, Motohide
    Mikami, Shigeru
    Sugiura, Nobuyuki
    Natsuki, Yutaka
    Azemoto, Ryosaku
    Suzuki, Noriaki
    Yokosuka, Osamu
    HEPATOLOGY INTERNATIONAL, 2013, 7 (01) : 144 - 152
  • [2] Response to Peginterferon-alfa 2b and Ribavirin in Japanese Patients with Chronic Hepatitis C Genotype 2
    Kanda, Tatsuo
    Imazeki, Fumio
    Azemoto, Ryosaku
    Yonemitsu, Yutaka
    Mikami, Shigeru
    Kita, Kazuhiko
    Takashi, Motohide
    Sunaga, Masahiko
    Wu, Shuang
    Nakamoto, Shingo
    Tawada, Akinobu
    Arai, Makoto
    Kato, Keizo
    Yoshida, Yu
    Koma, Yoshihiro
    Fujiwara, Keiichi
    Fukai, Kenichi
    Suzuki, Noriaki
    Yokosuka, Osamu
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (11) : 3335 - 3342
  • [3] Response to Peginterferon-alfa 2b and Ribavirin in Japanese Patients with Chronic Hepatitis C Genotype 2
    Tatsuo Kanda
    Fumio Imazeki
    Ryosaku Azemoto
    Yutaka Yonemitsu
    Shigeru Mikami
    Kazuhiko Kita
    Motohide Takashi
    Masahiko Sunaga
    Shuang Wu
    Shingo Nakamoto
    Akinobu Tawada
    Makoto Arai
    Keizo Kato
    Yu Yoshida
    Yoshihiro Koma
    Keiichi Fujiwara
    Kenichi Fukai
    Noriaki Suzuki
    Osamu Yokosuka
    Digestive Diseases and Sciences, 2011, 56 : 3335 - 3342
  • [4] Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients
    Dai, Chia-Yen
    Huang, Jee-Fu
    Hsieh, Ming-Yen
    Hou, Nai-Jen
    Lin, Zu-Yau
    Chen, Shinn-Chern
    Hsieh, Ming-Yuh
    Wang, Liang-Yen
    Chang, Wen-Yu
    Chuang, Wan-Long
    Yu, Ming-Lung
    JOURNAL OF HEPATOLOGY, 2009, 50 (04) : 712 - 718
  • [5] Randomized trial of peginterferon α-2a plus ribavirin versus peginterferon α-2b plus ribavirin for chronic hepatitis C in Japanese patients
    Shiho Miyase
    Katsuki Haraoka
    Yoshihiro Ouchida
    Yuko Morishita
    Shigetoshi Fujiyama
    Journal of Gastroenterology, 2012, 47 : 1014 - 1021
  • [6] Randomized trial of peginterferon α-2a plus ribavirin versus peginterferon α-2b plus ribavirin for chronic hepatitis C in Japanese patients
    Miyase, Shiho
    Haraoka, Katsuki
    Ouchida, Yoshihiro
    Morishita, Yuko
    Fujiyama, Shigetoshi
    JOURNAL OF GASTROENTEROLOGY, 2012, 47 (09) : 1014 - 1021
  • [7] Hepatitis C virus core Antigen as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon α-2b plus ribavirin
    Buti, M
    Mendez, C
    Schaper, M
    Sauleda, S
    Valdes, A
    Rodriguez-Frias, F
    Jardi, R
    Esteban, R
    JOURNAL OF HEPATOLOGY, 2004, 40 (03) : 527 - 532
  • [8] Peginterferon Alfa 2a/ribavirin versus Peginterferon Alfa 2b/ribavirin combination therapy in chronic Hepatitis C genotype 3
    Khan, Arif Q.
    Awan, Ali
    Shahbuddin, Sultan
    Igbal, Qamar
    GASTROENTEROLOGY, 2007, 132 (04) : A200 - A200
  • [9] A meta-analysis that compares the use of either peginterferon-alpha 2a or peginterferon-alpha 2b plus ribavirin for HCV infection
    Xiao, Nan
    Shi, Shuang
    Zhuang, Hui
    HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 2010, 2 : 99 - 109
  • [10] AGE AFFECTS ADHERENCE TO PEGINTERFERON-ALPHA AND RIBAVIRIN IN "DIFFICULT-TO-TREAT" PATIENTS WITH CHRONIC HEPATITIS C
    Lenci, I.
    Francioso, S.
    Carbone, M.
    De Leonardis, F.
    Baiocchi, L.
    Angelico, M.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S113 - S113